Climb Bio, Inc. CLYM Payments Of Stock Issuance Costs
Payments Of Stock Issuance Costs at other companies
Other financials
Where this comes from
Reported directly by Climb Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsOfStockIssuanceCosts.
The official record: Climb Bio, Inc.’s 10-K, filed March 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Climb Bio, Inc.'s payments of stock issuance costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Climb Bio, Inc.'s payments of stock issuance costs?
- Climb Bio, Inc. (CLYM) reported payments of stock issuance costs of $21.5K in Q4 2025.
- What does payments of stock issuance costs mean?
- Includes direct costs incurred in connection with the issuance of equity securities, such as legal, accounting, and underwriting fees. These costs are typically deducted from the proceeds of the equity offering and represent the friction of raising capital.